20.63
Schlusskurs vom Vortag:
$20.72
Offen:
$20.6309
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+2.59%
1M Leistung:
+13.35%
6M Leistung:
-0.16%
1J Leistung:
+0.00%
Cartesian Growth Corp Stock (GLBL) Company Profile
Firmenname
Cartesian Growth Corp
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie GLBL mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
GLBL
Cartesian Growth Corp
|
20.63 | 0 | 0 | 0 | 0 | 0.00 |
![]()
LION
Lionsgate Studios Corp
|
6.83 | 2.01B | 3.13B | 50.80M | 555.00M | 0.1772 |
![]()
AACT
Ares Acquisition Corporation Ii
|
11.26 | 695.30M | 0 | 16.92M | -1.35M | 0.29 |
![]()
ANSC
Agriculture Natural Solutions Acquisition Corp
|
10.72 | 461.01M | 0 | 1.30M | 0 | 0.0301 |
![]()
AAM
Aa Mission Acquisition Corp
|
10.31 | 453.37M | 0 | 0 | 0 | 0.00 |
![]()
EQV
Eqv Ventures Acquisition Corp
|
10.20 | 453.30M | 0 | 0 | 0 | 0.00 |
Cartesian Growth Corp Aktie (GLBL) Neueste Nachrichten
Berkley W R Corp Lowers Position in Cartesian Growth Co. II (NASDAQ:RENE) - MarketBeat
Cartesian Growth Corp II extends business combination period - Investing.com Australia
Opening Day: Smart Digital, Yuanbao make debuts - TipRanks
Gores Group's Latest SPAC Leads 3 IPOs Totaling $792M - Law360
Cartesian Growth Corp II extends business combination period By Investing.com - Investing.com South Africa
IPO NewsUS IPO Weekly Recap: Flurry of SPACs list and submit filings amid otherwise quiet IPO market - renaissancecapital.com
Cartesian Growth Corporation III Announces Pricing of Upsized $240 Million Initial Public Offering - Business Wire
Cartesian Growth Co. II (NASDAQ:RENE) Shares Sold by Crossingbridge Advisors LLC - MarketBeat
Spartan Fund Management Inc. Invests $295,000 in Cartesian Growth Co. II (NASDAQ:RENE) - MarketBeat
200,000 Shares in Cartesian Growth Co. II (NASDAQ:RENE) Acquired by Alpine Global Management LLC - MarketBeat
Cartesian Growth Co. II (NASDAQ:RENE) Trading Down 0%Time to Sell? - MarketBeat
Cartesian Robot Market to Grow at 7.1% CAGR, Valued at US$ 5.4 Billion by 2033 - openPR.com
Cartesian Growth Co. II (NASDAQ:RENE) Shares Down 0% – Time to Sell? - Defense World
Cartesian Warehouse Robotic Market will Touch New Development Level | ABB, KUKA, Fanuc, Yaskawa - newstrail.com
Cartesian Growth Co. II (NASDAQ:RENEU) Stock Price Down 0.4% – Should You Sell? - Defense World
RENE stock hits 52-week high at $11.89 amid market optimism - Investing.com Australia
Cartesian Growth Corp II extends business combination deadline By Investing.com - Investing.com South Africa
Cartesian Growth Corp II extends business combination deadline - Investing.com Australia
(RENE) Investment Analysis - news.stocktradersdaily.com
Brokerages Set Cartesian Therapeutics, Inc. (NASDAQ:RNAC) PT at $42.14 - Defense World
5 Hot Stock Buys for Investors in April - The Globe and Mail
Cartesian Growth Corp II SEC 10-K Report - TradingView
Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Holdings Raised by Bank of New York Mellon Corp - Defense World
(RENE) Long Term Investment Analysis - news.stocktradersdaily.com
RENE stock hits 52-week high at $11.86 amid growth optimism - Investing.com India
RENE stock hits 52-week high at $11.86 amid growth optimism By Investing.com - Investing.com South Africa
Mizuho Securities USA LLC Increases Holdings in Cartesian Growth Co. II (NASDAQ:RENE) - MarketBeat
Cartesian Growth Co. II (NASDAQ:RENE) Shares Sold by Periscope Capital Inc. - MarketBeat
RENE stock hits 52-week high at $11.83 amid market optimism - Investing.com Australia
RENE stock hits 52-week high at $11.83 amid market optimism By Investing.com - Investing.com South Africa
Global Gantry (Cartesian) Robot Market Poised to Reach USD 23.4 Billion by 2031 Amid Rising Automation Trends - WhaTech
Cartesian Growth Co. II (NASDAQ:RENE) Short Interest Update - MarketBeat
Learn to Evaluate (RENE) using the Charts - Stock Traders Daily
Cantor Fitzgerald maintains Overweight on Cartesian Therapeutics - Investing.com
Cantor Fitzgerald maintains Overweight on Cartesian Therapeutics By Investing.com - Investing.com UK
Cartesian Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Cartesian Growth Co. II (NASDAQ:RENE) Short Interest Down 25.0% in February - MarketBeat
Finanzdaten der Cartesian Growth Corp-Aktie (GLBL)
Es liegen keine Finanzdaten für Cartesian Growth Corp (GLBL) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Kapitalisierung:
|
Volumen (24h):